Dearest followers,
I will start the post by suggesting everyone to be responsible and stay at home. We are living difficult times due to the COVID-19 pandemie but right now we have to rediscover the value of being together. Staying at home or social distancing is the best way to stop the virus spreading effectively.
( click to enlarge )
Inovio Pharmaceuticals Inc (NASDAQ:INO) hit some scanners yesterday with some impressive volume and closed up 11.25%. Are more gains in store next week? From a technical standpoint, the stock on the hourly time frame has been consolidating above the hourly EMA200 for the next break higher. $7.85 is the recent high that needs to be broken with conviction (price/volume). After that break $11.93 will come in short order. Long setup on watch.
( click to enlarge )
SuperCom Ltd. Ordinary Shares (NASDAQ:SPCB) I purchased a large position on this small cap after the announcement of CEO that will buy up to 6M of shares and he said the current price does not reflect the value. "I believe the SPCB current stock price levels do not reflect the high intrinsic value of the company. This program provides me the ability to opportunistically acquire SuperCom shares and underscores my ongoing belief in the Company," commented Mr. Arie Trabelsi , President and CEO of SuperCom". Plus, the recent news makes me more interested: The company has won a new project with a California Central Valley county to provide employment and anger management services, valued at up to $3.8 million and they plan to leverage its proven, robust and scalable people tracking technology to aid in fighting the spread of the the coronavirus (COVID-19). Supercom is offering a new solution for quarantine and isolation monitoring to assist governments as they strive to contain and limit the reach of infectious diseases such as the coronavirus. I took advantage of the bad market on Friday to increase my position. 30m chart shows an increase in buying pressure (Accumulation).
( click to enlarge )
Myomo Inc (NYSEAMERICAN:MYO) continues to gain momentum. The stock has been on a nice uptrend recently and could be ready to breakout after decent volume in the last two trading sessions. I wouldn't be surprised to see this stock trade back to $5 or better in the short term.
( click to enlarge )
Document Security Systems, Inc. (NYSEAMERICAN:DSS) this stock deserves your attention next week. This company signed a letter of intent to acquire a coronavirus biotech last week (Impact Biomedical). Impact has a number of healthcare products in development including Equivir product which has been shown in studies to be effective as an antiviral against a broad range of viruses including in vitro efficacy against multiple strains of Influenza (H1N1, H3N2, H5N1, H7N9, Influenza B, Parainfluenza 3), Human Rhinovirus-14, Human Coronavirus-A, and Ebola. Equivir’s abilities to inhibit viruses via multiple targets have prompted further studies to test Equivir as a potential treatment of COVID-19. Looking at the hourly time frame, the stock looks right on the verge of a breakout. A decisive move above 21c has a measured move target of 26/27c initially, and any breakout should see price quickly move into the $.50s.
( click to enlarge )
OPKO Health (NASDAQ:OPK) I started buying this coronavirus play on Friday not because of the chart but due to its recent news and insider activity. At some point this stock will come on the radar of fund managers again. Might bounce here.
( click to enlarge )
Oragenics Inc (NYSEAMERICAN:OGEN) could be in the early stages of a technical breakout. The stock finally closed above the upper line of the falling wedge on the 4h chart for the first time since peak at 0.879. I will be watching very closely for news. The stock looks like it wants to run.
( click to enlarge )
T2 Biosystems Inc (NASDAQ:TTOO) The stock pulled back yesterday after a pretty significant breakout on Thursday. I like the idea of getting long here with a stop right below 32c. Company announced last week that it was awarded an Innovative Technology contract from Vizient, Inc., the largest member-driven health care performance improvement company in the country, covering its T2Dx Instrument, as well as the T2Bacteria and T2Candida Panels, that detect sepsis-causing bacterial and fungal pathogens directly from whole blood. Plus, company still tweeting that T2Bio’s Panels enable rapid ID of sepsis-causing secondary infections, providing ID in 3-5 hrs. direct from whole blood, enabling Drs. to target therapy for patients with co-infections associated with COVID-19. Still in play for me.
( click to enlarge )
China Pharma Holdings, Inc.(NYSEAMERICAN:CPHI) One of the best setups out there. I love to play falling wedge patterns. A breakout in the direction of the previous trend confirms the continuation patterns. This stock is breaking out again of a falling wedge which is generally a bullish signal. Definitely on watch next week.
During the day I tweet many times to my readers. I encourage everybody to subscribe AC Investor Blog twitter and newsletter, so you can receive my trade ideas and stock news in real time.
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
Labels: CPHI, DSS, INO, MYO, OGEN, OPK, SPCB, TTOO